•2026•20 Episodes•36K+
Elena begins as the scientist behind MyoRegen, a breakthrough that quickly becomes the center of a ruthless power struggle. She is betrayed in a deadly fire, and Julian and Serena move fast to seize her labs, patents, and the cure she spent years building. The world is told Elena is gone, while the stolen work is treated as a corporate asset rather than a medical promise. Haley, the child tied to the treatment, becomes the most vulnerable piece in the conflict because her dependence on the medicine can be used to force compliance. Elena survives the fire, is hidden by a rescuer, and learns that Haley is still alive, which gives her a reason to keep fighting. Meanwhile, Julian and Charles try to reproduce the formula from the stolen records, but every attempt fails because a crucial final step was never written down. That missing step turns Haley’s body into the company’s next target, since her blood or marrow may be the only way to rebuild the perfected reagent. As pressure rises, doctors and executives push dangerous testing and extraction plans despite the obvious risk to the child. The story widens into a corporate-medical thriller where secrecy, obedience, and profit collide inside the company’s facilities. A strict workplace culture enforces contamination rules and obedience, showing how little room there is for dissent. Inside the hidden biotech operation, a 72-hour deadline drives the team toward increasingly desperate choices for wealthy buyers. When the synthesis remains incomplete, the people in charge consider using the child as backup material to save the project. Charles tries to manage the science while also avoiding blame, but the project keeps destabilizing. Resistance begins to form from within, and sabotage starts to undermine the operation. A failed stem-cell test and a looming audit expose the plan to use a child to hide the failure. Lynn, who is Elena under a new identity, realizes her child is being used as cover and moves to stop the harvest. The conflict spills into the corporate tower, where sabotage triggers an ammonia leak, lockdowns, and a search for the culprit. By the end of the batch, Lynn and Sarah are actively resisting the system, Serena is investigating the sabotage, and Julian’s empire is under pressure from both internal betrayal and the threat of exposure.
Elena begins as the scientist behind MyoRegen, a breakthrough that quickly becomes the center of a ruthless power struggle. She is betrayed in a deadly fire, and Julian and Serena move fast to seize her labs, patents, and the cure she spent years building. The world is told Elena is gone, while the stolen work is treated as a corporate asset rather than a medical promise. Haley, the child tied to the treatment, becomes the most vulnerable piece in the conflict because her dependence on the medicine can be used to force compliance. Elena survives the fire, is hidden by a rescuer, and learns that Haley is still alive, which gives her a reason to keep fighting. Meanwhile, Julian and Charles try to reproduce the formula from the stolen records, but every attempt fails because a crucial final step was never written down. That missing step turns Haley’s body into the company’s next target, since her blood or marrow may be the only way to rebuild the perfected reagent. As pressure rises, doctors and executives push dangerous testing and extraction plans despite the obvious risk to the child. The story widens into a corporate-medical thriller where secrecy, obedience, and profit collide inside the company’s facilities. A strict workplace culture enforces contamination rules and obedience, showing how little room there is for dissent. Inside the hidden biotech operation, a 72-hour deadline drives the team toward increasingly desperate choices for wealthy buyers. When the synthesis remains incomplete, the people in charge consider using the child as backup material to save the project. Charles tries to manage the science while also avoiding blame, but the project keeps destabilizing. Resistance begins to form from within, and sabotage starts to undermine the operation. A failed stem-cell test and a looming audit expose the plan to use a child to hide the failure. Lynn, who is Elena under a new identity, realizes her child is being used as cover and moves to stop the harvest. The conflict spills into the corporate tower, where sabotage triggers an ammonia leak, lockdowns, and a search for the culprit. By the end of the batch, Lynn and Sarah are actively resisting the system, Serena is investigating the sabotage, and Julian’s empire is under pressure from both internal betrayal and the threat of exposure.
The Biotech Secret: Her Undercover Revenge is a Thriller Series in English, streaming on Kuku TV.
The Biotech Secret: Her Undercover Revenge has 20 episodes, watched over 36K+ times on Kuku TV.
The Biotech Secret: Her Undercover Revenge is available to watch in English on Kuku TV.
The Biotech Secret: Her Undercover Revenge was released in 2026 and is streaming on Kuku TV.
The Biotech Secret: Her Undercover Revenge is rated A.
You can watch The Biotech Secret: Her Undercover Revenge online on Kuku TV or download the Kuku TV app to start playing. Open any episode above to start watching instantly.
